Spots Global Cancer Trial Database for Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma
Official Title: A Pilot Study of Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients With Relapsed/Refractory Hodgkin Lymphoma
Study ID: NCT01207921
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study to evaluate the feasibility of lenalidomide maintenance therapy in patients with relapsed Hodgkin lymphoma after autologous transplant
Detailed Description: Primary Objectives -To evaluate the feasibility of lenalidomide maintenance therapy in patients with relapsed Hodgkin lymphoma after autologous stem cell transplant, as measured by dropout rate. Secondary Objectives * To assess overall survival, event free survival, and progression free survival. * To establish the adverse event profile of long-term maintenance therapy with lenalidomide in this patient population. * To assess the conversion of partial response/stable disease post-ASCT to complete response. * To evaluate changes in immune cell number and function and plasma proteins before, during, and after lenalidomide therapy (correlative studies).
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Washington University School of Medicine, Saint Louis, Missouri, United States
Wake Forest University, Winston-Salem, North Carolina, United States
Ohio State University, Columbus, Ohio, United States
Contact Details
Name: Todd Fehniger, M.D., Ph.D.
Affiliation: Washington University School of Medicine
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
